Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShare-based Compensation (IS)Shares Outstanding (Weighted Average)
Others
Ratios

Addex Therapeutics (ADXN) EPS (Basic): 2022-2025

Historic EPS (Basic) for Addex Therapeutics (ADXN) over the last 3 years, with Jun 2025 value amounting to -$0.01.

  • Addex Therapeutics' EPS (Basic) rose 63.59% to -$0.01 in Q2 2025 from the same period last year, while for Jun 2025 it was -$0.05, marking a year-over-year increase of 46.02%. This contributed to the annual value of $0.08 for FY2024, which is 151.04% up from last year.
  • Per Addex Therapeutics' latest filing, its EPS (Basic) stood at -$0.01 for Q2 2025, which was down 83.39% from -$0.01 recorded in Q1 2025.
  • Over the past 5 years, Addex Therapeutics' EPS (Basic) peaked at -$0.01 during Q1 2025, and registered a low of -$0.48 during Q4 2022.
  • In the last 3 years, Addex Therapeutics' EPS (Basic) had a median value of -$0.02 in 2024 and averaged -$0.02.
  • In the last 5 years, Addex Therapeutics' EPS (Basic) skyrocketed by 97.17% in 2023 and then plummeted by 66.97% in 2024.
  • Quarterly analysis of 4 years shows Addex Therapeutics' EPS (Basic) stood at -$0.48 in 2022, then skyrocketed by 97.17% to -$0.01 in 2023, then dropped by 2.22% to -$0.01 in 2024, then soared by 63.59% to -$0.01 in 2025.
  • Its last three reported values are -$0.01 in Q2 2025, -$0.01 for Q1 2025, and -$0.01 during Q4 2024.